0001209191-17-009292.txt : 20170209 0001209191-17-009292.hdr.sgml : 20170209 20170209193327 ACCESSION NUMBER: 0001209191-17-009292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170207 FILED AS OF DATE: 20170209 DATE AS OF CHANGE: 20170209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2065821600 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bishop Hans Edgar CENTRAL INDEX KEY: 0001480212 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36781 FILM NUMBER: 17589120 MAIL ADDRESS: STREET 1: 60 WEST 66TH STREET, 26A CITY: NEW YORK STATE: NY ZIP: 10023 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-07 0 0001594864 Juno Therapeutics, Inc. JUNO 0001480212 Bishop Hans Edgar C/O 307 WESTLAKE AVENUE N STE 300 SEATTLE WA 98109 1 1 0 0 CEO & President Common Stock 2017-02-07 4 A 0 44177 0.00 A 2491036 D Stock Option (Right to Buy) 20.76 2017-02-07 4 A 0 205823 0.00 A 2027-02-06 Common Stock 205823 205823 D Represents restricted stock units ("RSUs") granted pursuant to the 2014 Equity Incentive Plan. 25% of the RSUs vest on each anniversary of February 7, 2017. 1/48th of the shares subject to the option vests and becomes exercisable on March 7, 2017 and 1/48th of the shares subject to the option vests and becomes exercisable monthly thereafter. /s/ Zachary D. Hale, attorney-in-fact 2017-02-09